184 related articles for article (PubMed ID: 37831111)
1. Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer.
Takatsu F; Suzawa K; Tomida S; Thu YM; Sakaguchi M; Toji T; Ohki M; Tsudaka S; Date K; Matsuda N; Iwata K; Zhu Y; Nakata K; Shien K; Yamamoto H; Nakayama A; Okazaki M; Sugimoto S; Toyooka S
J Mol Med (Berl); 2023 Dec; 101(12):1603-1614. PubMed ID: 37831111
[TBL] [Abstract][Full Text] [Related]
2. Single-cell and spatial transcriptomics reveal POSTN
Chen C; Guo Q; Liu Y; Hou Q; Liao M; Guo Y; Zang Y; Wang F; Liu H; Luan X; Liang Y; Guan Z; Li Y; Liu H; Dong X; Zhang X; Liu J; Xu Q
Clin Transl Med; 2023 Dec; 13(12):e1515. PubMed ID: 38115703
[TBL] [Abstract][Full Text] [Related]
3. Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer-associated fibroblast.
Ochi K; Suzawa K; Thu YM; Takatsu F; Tsudaka S; Zhu Y; Nakata K; Takeda T; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Shien T; Okamoto Y; Tomida S; Toyooka S
Cancer Sci; 2022 Oct; 113(10):3428-3436. PubMed ID: 35871750
[TBL] [Abstract][Full Text] [Related]
4. Single-cell Transcriptomic Analysis Reveals an Immunosuppressive Network Between POSTN CAFs and ACKR1 ECs in TKI-resistant Lung Cancer.
Wang Z; Yan N; Sheng H; Xiao Y; Sun J; Cao C
Cancer Genomics Proteomics; 2024; 21(1):65-78. PubMed ID: 38151287
[TBL] [Abstract][Full Text] [Related]
5. MET inhibitor, capmatinib overcomes osimertinib resistance via suppression of MET/Akt/snail signaling in non-small cell lung cancer and decreased generation of cancer-associated fibroblasts.
Zhu K; Lv Z; Xiong J; Zheng H; Zhang S; Jin H; Yu L; Li Z; Zhang J; Li C; Liang P
Aging (Albany NY); 2021 Feb; 13(5):6890-6903. PubMed ID: 33621951
[TBL] [Abstract][Full Text] [Related]
6. Role of Periostin Expression in Non-Small Cell Lung Cancer: Periostin Silencing Inhibits the Migration and Invasion of Lung Cancer Cells via Regulation of MMP-2 Expression.
Ratajczak-Wielgomas K; Kmiecik A; Dziegiel P
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163164
[TBL] [Abstract][Full Text] [Related]
7. IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling.
Shintani Y; Fujiwara A; Kimura T; Kawamura T; Funaki S; Minami M; Okumura M
J Thorac Oncol; 2016 Sep; 11(9):1482-92. PubMed ID: 27287412
[TBL] [Abstract][Full Text] [Related]
8. Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFκB signaling.
Ren Y; Cao L; Wang L; Zheng S; Zhang Q; Guo X; Li X; Chen M; Wu X; Furlong F; Meng Z; Xu K
Cell Death Dis; 2021 Sep; 12(10):858. PubMed ID: 34552063
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts strengthen cell proliferation and EGFR TKIs resistance through aryl hydrocarbon receptor dependent signals in non-small cell lung cancer.
Feng H; Cao B; Peng X; Wei Q
BMC Cancer; 2022 Jul; 22(1):764. PubMed ID: 35831824
[TBL] [Abstract][Full Text] [Related]
10. Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-κB and TGF-β2 signaling.
Lin SC; Liao YC; Chen PM; Yang YY; Wang YH; Tung SL; Chuang CM; Sung YW; Jang TH; Chuang SE; Wang LH
J Biomed Sci; 2022 Dec; 29(1):109. PubMed ID: 36550569
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Stromal Periostin Expression in Non-Small Cell Lung Cancer.
Ratajczak-Wielgomas K; Kmiecik A; Grzegrzołka J; Piotrowska A; Gomulkiewicz A; Partynska A; Pawelczyk K; Nowinska K; Podhorska-Okolow M; Dziegiel P
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987711
[TBL] [Abstract][Full Text] [Related]
12. Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation.
Yoshida T; Ishii G; Goto K; Neri S; Hashimoto H; Yoh K; Niho S; Umemura S; Matsumoto S; Ohmatsu H; Iida S; Niimi A; Nagai K; Ohe Y; Ochiai A
Clin Cancer Res; 2015 Feb; 21(3):642-51. PubMed ID: 25388165
[TBL] [Abstract][Full Text] [Related]
13. Human lung cancer-associated fibroblasts enhance motility of non-small cell lung cancer cells in co-culture.
Kim SH; Choe C; Shin YS; Jeon MJ; Choi SJ; Lee J; Bae GY; Cha HJ; Kim J
Anticancer Res; 2013 May; 33(5):2001-9. PubMed ID: 23645749
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced PDL-1 expression in cancer-associated fibroblasts promotes chemoresistance in NSCLC.
Heenatigala Palliyage G; Samart P; Bobbala S; Rojanasakul LW; Coyle J; Martin K; Callery PS; Rojanasakul Y
Lung Cancer; 2023 Jul; 181():107258. PubMed ID: 37245409
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblast-derived periostin promotes papillary thyroid tumor growth through integrin-FAK-STAT3 signaling.
Jin X; Deng Q; Ye S; Liu S; Fu Y; Liu Y; Wu G; Ouyang G; Wu T
Theranostics; 2024; 14(7):3014-3028. PubMed ID: 38773979
[No Abstract] [Full Text] [Related]
16. Sulfonylurea receptor 1-expressing cancer cells induce cancer-associated fibroblasts to promote non-small cell lung cancer progression.
Chen H; Zhao L; Meng Y; Qian X; Fan Y; Zhang Q; Wang C; Lin F; Chen B; Xu L; Huang W; Chen J; Wang X
Cancer Lett; 2022 Jun; 536():215611. PubMed ID: 35240233
[TBL] [Abstract][Full Text] [Related]
17. Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer.
Yue H; Li W; Chen R; Wang J; Lu X; Li J
Gynecol Oncol; 2021 Feb; 160(2):530-538. PubMed ID: 33317907
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of annexin A2 and cancer-associated fibroblasts in advanced non-small cell lung cancer: Implication in epithelial-mesenchymal transition and gefitinib resistance.
Ibrahim FM; Helal DS; Ali DA; Abd-Ellatif RN; Elkady AM; Sharshar R; Gharib F; Abo Elnasr M; El-Guindy DM
Pathol Res Pract; 2023 Jan; 241():154293. PubMed ID: 36586309
[TBL] [Abstract][Full Text] [Related]
19. The MEK/ERK/miR-21 Signaling Is Critical in Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer Cells.
Huang WC; Yadav VK; Cheng WH; Wang CH; Hsieh MS; Huang TY; Lin SF; Yeh CT; Kuo KT
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885115
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling.
Yi Y; Zeng S; Wang Z; Wu M; Ma Y; Ye X; Zhang B; Liu H
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):793-803. PubMed ID: 29253515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
